COLIZZI, Marco
 Distribuzione geografica
Continente #
EU - Europa 1.267
NA - Nord America 990
AS - Asia 687
OC - Oceania 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 2.972
Nazione #
US - Stati Uniti d'America 980
CN - Cina 480
IT - Italia 302
FR - Francia 186
RU - Federazione Russa 180
GB - Regno Unito 165
IE - Irlanda 162
SE - Svezia 139
SG - Singapore 101
DE - Germania 67
VN - Vietnam 53
ID - Indonesia 20
FI - Finlandia 17
UA - Ucraina 16
AU - Australia 12
JP - Giappone 12
BR - Brasile 9
CA - Canada 9
NL - Olanda 7
IN - India 5
CH - Svizzera 4
IL - Israele 4
DK - Danimarca 3
RO - Romania 3
TR - Turchia 3
BE - Belgio 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
SD - Sudan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HK - Hong Kong 1
HR - Croazia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 2.972
Città #
Chandler 297
Dublin 157
Southend 142
Beijing 108
Lawrence 73
Princeton 73
Wilmington 66
Singapore 59
Ashburn 51
Jacksonville 51
Nanjing 43
Verona 33
Dong Ket 28
Sindelfingen 26
Hebei 24
Jinan 23
Shenyang 23
New York 21
Jakarta 19
Guangdong 16
Ningbo 16
Bolzano 15
Tianjin 15
Nanchang 14
Changsha 13
Guangzhou 13
Haikou 13
Milan 13
Redwood City 13
Redmond 12
San Francisco 12
Chicago 11
Seattle 11
Hangzhou 10
Kent 10
Norwalk 10
Ann Arbor 9
Bologna 9
Helsinki 9
Rome 9
Zhengzhou 9
Lanzhou 8
Lappeenranta 8
Taizhou 8
Tokyo 8
Adrano 7
Boardman 6
Dearborn 6
Fairfield 6
Falls Church 6
Houston 6
Rio De Janeiro 6
Taiyuan 6
Toronto 6
Amsterdam 5
Dongguan 5
Ferrara 5
Jiaxing 5
Melbourne 5
Broomfield 4
Esslingen am Neckar 4
Lambeth 4
Nuremberg 4
Perugia 4
Watford 4
Woodbridge 4
Campodarsego 3
Clearwater 3
Dallas 3
Sarnico 3
Sommacampagna 3
Staranzano 3
Tel Aviv 3
Washington 3
Adelaide 2
Alba 2
Athens 2
Berlin 2
Bury St Edmunds 2
Cairate 2
Canberra 2
Capriolo 2
Castiglione Cosentino 2
Catania 2
Cesenatico 2
Chiyoda-ku 2
Council Bluffs 2
Cutrofiano 2
Dundee 2
Frigento 2
Fuzhou 2
Gargallo 2
Groningen 2
Hyderabad 2
Lagonegro 2
Los Angeles 2
Ludwigshafen am Rhein 2
Lugano 2
Mentana 2
Merlara 2
Totale 1.795
Nome #
Lo stigma nella salute mentale 152
Psychosocial and behavioral impact of COVID-19 in autism spectrum disorder: an online parent survey 70
Postural control in childhood: investigating the neurodevelopmental gradient hypothesis 70
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 70
Medically unexplained symptoms in the times of Covid-19 pandemic: a case-report 67
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 66
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the COVID-19 pandemic: an online student survey 63
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 62
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: is there a role for motor abnormalities in atypical neurodevelopment? 62
Do cannabis users develop tolerance for the psychoactive effects of delta-9-tetrahydrocannabinol? An fMRI study 58
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with Tourette syndrome: preliminary evidence from a case series 57
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 56
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) 53
Descriptive psychopathology of the acute effects of intravenous Delta-9-Tetrahydrocannabinol administration in humans 52
Is the adolescent brain at greater vulnerability to the effects of cannabis? A narrative review of the evidence 51
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 50
Cannabis and cognition: connecting the dots towards the understanding of the relationship 50
Attachment styles in transsexual patients and clinical and nonclinical control groups: a response 49
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 47
Gender-oriented mental health prevention: a reappraisal 47
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 46
Cannabis use and the development of tolerance: a systematic review of human evidence 46
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 46
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: a systematic review of human and animal evidence 46
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 45
Cannabis: neuropsychiatry and its effects on brain and behavior 45
Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria 45
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study 44
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 43
Dissociative symptoms in individuals with gender dysphoria: is the elevated prevalence real? 42
The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida: A summary of topics and trends 41
Additional evidence for neuropsychiatric manifestations in Mosaic Trisomy 20: a case report and brief review 41
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 41
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 40
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 40
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 39
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 38
Neurocognitive effects of cannabis: Lessons learned from human experimental studies 38
Differential gene expression analysis in blood of first episode psychosis patients 38
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis 38
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 38
Cannabis and psychosis: what do we know and what should we do? 37
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 37
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 36
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 35
To treat or not to treat: puberty suppression in childhood-onset gender dysphoria 34
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 34
S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE 33
Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style 33
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 33
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review 33
Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care? 33
Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior 32
Epigenetic mediation of AKT1 rs1130233's Effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing 32
Substance use, medication adherence and outcome one year following a first episode of psychosis 31
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 31
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study 31
S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS 30
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control study 30
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 29
Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition 28
The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review 28
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition 28
Editorial: The endocannabinoid system: filling the translational gap between neuroscience and psychiatry 28
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 26
The neural substrate of reward anticipation in health: a meta-analysis of fMRI findings in the monetary incentive delay task 25
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use 25
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure 24
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 23
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis 21
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 20
The relationship between dissociative experiences and cannabis use: a systematic review 19
Hyperprolactinaemia in first episode psychosis: a longitudinal assessment 19
Totale 3.070
Categoria #
all - tutte 14.836
article - articoli 14.239
book - libri 0
conference - conferenze 224
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 373
Totale 29.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020162 0 0 0 3 8 5 15 30 21 28 23 29
2020/2021530 84 53 37 101 73 30 2 14 27 15 28 66
2021/2022443 37 52 9 33 28 13 7 45 19 15 18 167
2022/2023930 87 81 103 129 115 211 5 53 107 10 21 8
2023/2024552 22 39 69 45 41 91 35 68 8 23 83 28
2024/2025312 67 84 48 113 0 0 0 0 0 0 0 0
Totale 3.070